Management of non-melanoma skin cancer.

OBJECTIVES To review types of, and treatment for, non-melanoma skin cancer (NMSC): basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and less common NMSC. DATA SOURCES Standards of care, dermatology texts, peer-reviewed journals. CONCLUSION BCC grows slowly and rarely metastasizes; some BCC subtypes can be aggressive and destructive. Early treatment of SCC is usually successful; untreated SCC will penetrate underlying tissue, invade lymph nodes, and metastasize. Treatment options for NMSC are based on patient and tumor characteristics, which determine whether a lesion is low or high risk for cancer recurrence after treatment. IMPLICATIONS FOR NURSING PRACTICE Nurses are integral for educating patients about measures to prevent new skin cancers and for monitoring for recurrence of NMSC.

[1]  Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer , 1992 .

[2]  J. Fine,et al.  Genetic Disorders Predisposing to Skin Malignancy , 2011 .

[3]  L. Hovelius,et al.  Report of Five Cases , 1977 .

[4]  Christopher J. Arpey,et al.  Aggressive basal cell carcinoma: Presentation, pathogenesis, and management , 2004, Cancer and Metastasis Reviews.

[5]  M. Veness,et al.  Role of modern radiotherapy in treating skin cancer , 2003, The Australasian journal of dermatology.

[6]  Murad Alam,et al.  The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. , 2011, Journal of the American Academy of Dermatology.

[7]  S. Varma,et al.  Facial basal cell carcinoma , 2012, BMJ : British Medical Journal.

[8]  J. L. Smith,et al.  Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 , 2011 .

[9]  J. Lo,et al.  Metastatic basal cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[10]  L. Glenn,et al.  Client characteristics and practice patterns of nurse practitioners and physicians. , 1999, The Nurse practitioner.

[11]  B. Hanusa,et al.  New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. , 1992, Journal of the American Academy of Dermatology.

[12]  J. D. de Fijter,et al.  Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors , 2010, Transplantation.

[13]  R. Carroll,et al.  Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. , 1989, The Journal of dermatologic surgery and oncology.

[14]  A. Kopf,et al.  Recurrence rates of treated basal cell carcinomas. , 1993, The Journal of dermatologic surgery and oncology.

[15]  C. Dirksen,et al.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. , 2008, The Lancet. Oncology.

[16]  Cary P Gross,et al.  Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology. , 2011, Archives of dermatology.

[17]  A. Cognetta,et al.  Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. , 2012, Journal of the American Academy of Dermatology.

[18]  A. Oseroff,et al.  Basal cell and squamous cell skin cancers. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[19]  C. Grin,et al.  Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. , 1992, The Journal of dermatologic surgery and oncology.

[20]  N. Scheinfeld,et al.  Evidence‐Based Review of the Use of Cryosurgery in Treatment of Basal Cell Carcinoma , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[21]  S. Mayne,et al.  Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma , 2011, The Journal of investigative dermatology.

[22]  E. Stockfleth,et al.  Topical Treatment of Skin Cancer , 2011 .

[23]  D. Kuijpers,et al.  Basal Cell Carcinoma , 2002, American journal of clinical dermatology.

[24]  M. Karagas,et al.  Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. , 1996, Journal of the National Cancer Institute.

[25]  R. Stern,et al.  Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.

[26]  E. Epstein.  Fluorouracil paste treatment of thin basal cell carcinomas. , 1985, Archives of dermatology.

[27]  J. Q. Rosso,et al.  Intralesional agents in the management of cutaneous malignancy: A review , 2012 .

[28]  M. Singer,et al.  Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. , 2000, Archives of dermatology.

[29]  C. Curiel-Lewandrowski,et al.  A systematic review of advanced practice nurses’ skin cancer assessment barriers, skin lesion recognition skills, and skin cancer training activities , 2011, Journal of the American Academy of Nurse Practitioners.

[30]  L. Goldberg,et al.  Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. , 1994, The Journal of dermatologic surgery and oncology.

[31]  A. Moore,et al.  Recurrence Rates of Primary Nonmelanoma Skin Cancers Treated by Surgical Excision Compared to Electrodesiccation‐Curettage in a Private Dermatological Practice , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[32]  L. Schouten,et al.  A systematic review of treatment modalities for primary basal cell carcinomas. , 1999, Archives of dermatology.

[33]  A. Marghoob,et al.  Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma , 1993 .

[34]  H. Comber,et al.  A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.

[35]  J. Ratz,et al.  Sebaceous carcinoma of the eyelid treated with Mohs' surgery. , 1986, Journal of the American Academy of Dermatology.

[36]  J. Feyzi,et al.  Metastatic basal cell carcinoma. Report of five cases , 1994, Cancer.

[37]  T. H. Nguyen,et al.  Nonmelanoma skin cancer , 2002, Current treatment options in oncology.

[38]  D. Leffell,et al.  Management of nonmelanoma skin cancer in 2007 , 2007, Nature Clinical Practice Oncology.

[39]  R. Carroll,et al.  Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.

[40]  R. Piccinno,et al.  Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. , 1999, Journal of the American Academy of Dermatology.

[41]  C. Cockerell,et al.  Actinic Keratoses and Other Precursors of Keratinocytic Cutaneous Malignancies , 2011 .

[42]  E. Alexopoulos,et al.  Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open‐label study of cryosurgery during continued imiquimod application , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[43]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[44]  A. Sheridan,et al.  Curettage, electrosurgery and skin cancer , 2000, The Australasian journal of dermatology.

[45]  M. Veness,et al.  Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. , 2007, Australasian radiology.

[46]  P. Kennedy,et al.  Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. , 1992, The Australian and New Zealand journal of surgery.

[47]  M. Veness,et al.  Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma. , 2005, Australasian radiology.

[48]  H. Greenway,et al.  Merkel cell carcinoma , 2000, Cancer.

[49]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[50]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[51]  S. Lippman,et al.  Mortality risk from squamous cell skin cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  Victoria L. Lazareth.  Dermatologic Care of the Transplant Patient: Part II , 2010 .

[53]  Howard W. Rogers,et al.  A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. , 2009, Journal of the American Academy of Dermatology.

[54]  J. Bernhard,et al.  Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. , 2009, Archives of dermatology.

[55]  S. Dinehart,et al.  Squamous Cell Carcinoma , 2011 .

[56]  K. Nouri,et al.  Lasers in the Treatment of Nonmelanoma Skin Cancer , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[57]  J. Jorizzo,et al.  Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. , 2007, Journal of drugs in dermatology : JDD.

[58]  M. Chren,et al.  Variation in Care for Nonmelanoma Skin Cancer in a Private Practice and a Veterans Affairs Clinic , 2004, Medical care.

[59]  G. Sánchez-Aniceto,et al.  Microcystic adnexal carcinoma , 1991, European Journal of Plastic Surgery.

[60]  M. Ross,et al.  Sarcomas of the Skin , 2011 .

[61]  J. Cooper.  Radiation Therapy in the Treatment of Skin Cancers , 2011 .

[62]  Victoria Beebe,et al.  A Review of Merkel Cell Carcinoma for Dermatology Nurses , 2009 .

[63]  E. Alexopoulos,et al.  Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label study. , 2011, European journal of dermatology : EJD.

[64]  E. G. Kuflik.  Cryosurgery for Skin Cancer: 30‐Year Experience and Cure Rates , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[65]  R. Sengelmann,et al.  Nonsurgical Treatment Modalities for Primary Cutaneous Malignancies , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[66]  David J Goldberg,et al.  A Review of Laser and Photodynamic Therapy for the Treatment of Nonmelanoma Skin Cancer , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[67]  A. Kopf,et al.  Curettage-electrodesiccation treatment of basal cell carcinomas. , 1977, Archives of dermatology.

[68]  A. Sober,et al.  Improvements in the Staging of Cutaneous Squamous-Cell Carcinoma in the 7th Edition of the AJCC Cancer Staging Manual , 2010, Annals of Surgical Oncology.

[69]  H. von Domarus,et al.  Metastatic basal cell carcinoma , 1984 .

[70]  A. Boutten.  Squamous cell carcinoma (SCC) , 2006 .

[71]  E. Billingsley.  A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics , 2012 .

[72]  B. Gastman,et al.  What Is the Best Surgical Margin for a Basal Cell Carcinoma: A Meta-Analysis of the Literature , 2010, Plastic and reconstructive surgery.

[73]  F. Cole,et al.  Procedures Taught in Family Nurse Practitioner Programs in the United States , 2003, Journal of the American Academy of Nurse Practitioners.

[74]  R. Stern,et al.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.

[75]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[76]  B. Coldiron,et al.  AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. , 2012, Journal of the American Academy of Dermatology.

[77]  V. Gebski,et al.  Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy , 2012, Head & neck.

[78]  D Ratner,et al.  Cutaneous squamous-cell carcinoma. , 2001, The New England journal of medicine.

[79]  S. Mills,et al.  Microcystic adnexal carcinoma. , 1984, Journal of the American Academy of Dermatology.

[80]  R. Carroll,et al.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.

[81]  S. Ibrahim,et al.  Surgical Excision for Non-Melanoma Skin Cancer , 2011 .